产品标题 产品货号 产品规格 厂家
CMPK1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4048561 kitORIGENE TECHNOLOGIES
Cml5 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035181 kitORIGENE TECHNOLOGIES
Cmpk1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035191 kitORIGENE TECHNOLOGIES
CMPK2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4187941 kitORIGENE TECHNOLOGIES
CMPK1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30485610 ugORIGENE TECHNOLOGIES
CMBL Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30171110 ugORIGENE TECHNOLOGIES
Cmpk2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035201 kitORIGENE TECHNOLOGIES
CMPK2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31879410 ugORIGENE TECHNOLOGIES
Cmss1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5035211 kitORIGENE TECHNOLOGIES
C530008M17Rik - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5023821 kitORIGENE TECHNOLOGIES
CMT1A duplicated region transcript 1 (CDRT1) from ORIGENE TECHNOLOGIESLY416681100 ugORIGENE TECHNOLOGIES
CMSS1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4008591 kitORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCS6485045x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, lobular, metastatic from ORIGENE TECHNOLOGIESCS5218005x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, lobular, metastatic from ORIGENE TECHNOLOGIESCS5450735x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, lobular, metastatic from ORIGENE TECHNOLOGIESCS7127905x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, lobular, metastatic (protein lysate) from ORIGENE TECHNOLOGIESCP627491150 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, lobular, metastatic from ORIGENE TECHNOLOGIESCS6274945x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, lobular (protein lysate) from ORIGENE TECHNOLOGIESCP537799150 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, lobular (protein lysate) from ORIGENE TECHNOLOGIESCP543487150 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metaplastic, squamous and sarcomatous features (triple negative) from ORIGENE TECHNOLOGIESCS6173365x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metaplastic, recurrent from ORIGENE TECHNOLOGIESCS6214645x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCS5001555x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCS5279505x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCS5187775x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCS6011175x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCS6246485x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCS5356475x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCS6327115x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCS6424165x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCS6518455x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCS6470135x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, mucinous from ORIGENE TECHNOLOGIESCS5101865x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, micropapillary from ORIGENE TECHNOLOGIESCS5319595x5umORIGENE TECHNOLOGIES
Human Breast; Adenoma of breast, tubular from ORIGENE TECHNOLOGIESCS6442765x5umORIGENE TECHNOLOGIES
Human Breast; Adenoma of breast, tubular from ORIGENE TECHNOLOGIESCS6442775x5umORIGENE TECHNOLOGIES
Human Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCS7011435x5umORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, papillary serous, borderline from ORIGENE TECHNOLOGIESCR5609635 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, papillary serous, borderline from ORIGENE TECHNOLOGIESCR5609975 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: right-Tumor of ovary, papillary serous, borderline from ORIGENE TECHNOLOGIESCR566335n/aORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, papillary serous, borderline from ORIGENE TECHNOLOGIESCR5620065 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5601335 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5604995 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5609935 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5612525 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, papillary serous, borderline from ORIGENE TECHNOLOGIESCR5610795 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5615745 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5621215 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: right; Tumor of ovary, serous, borderline from ORIGENE TECHNOLOGIESCR5621345 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Tumor of ovary, borderline from ORIGENE TECHNOLOGIESCR5621315 ugORIGENE TECHNOLOGIES
 |< < 1288 1289 1290 1291 1292 1293 1294 1295 1296 > >| 第 1294/6274 页